World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Homepage

Online Submission

Number of total visits: 31331219

Number of visits today: 5820

Number of downloads: 13896917

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Yamashita S, Hattori N, Fujii S, Yamaguchi T, Takahashi M, Hozumi Y, Kogawa T, El-Omar O, Liu YY, Arai N, Mori A, Higashimoto H, Ushijima T, Mukai H. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy. Sci Rep 2020;10:15530. [PMID: 32968149 DOI: 10.1038/s41598-020-72661-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]

For:

Yamashita S, Hattori N, Fujii S, Yamaguchi T, Takahashi M, Hozumi Y, Kogawa T, El-Omar O, Liu YY, Arai N, Mori A, Higashimoto H, Ushijima T, Mukai H. Multi-omics analyses identify HSD17B4 methylation-silencing as a predictive and response marker of HER2-positive breast cancer to HER2-directed therapy. Sci Rep 2020;10:15530. [PMID: 32968149 DOI: 10.1038/s41598-020-72661-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]

Number	Citing Articles
1	Di Cara F, Savary S, Kovacs WJ, Kim P, Rachubinski RA. The peroxisome: an up-and-coming organelle in immunometabolism. Trends Cell Biol 2022:S0962-8924(22)00140-4. [PMID: 35788297 DOI: 10.1016/j.tcb.2022.06.001] [Reference Citation Analysis]
2	Ma J, Chen W, Hu Z, Huang J, Guo C, Zou C, Yang G. Rare ocular toxicity induced by pertuzumab/QL1209 in healthy chinese subjects: case reports and whole-exome sequencing analysis. Invest New Drugs 2022. [PMID: 35596833 DOI: 10.1007/s10637-022-01256-0] [Reference Citation Analysis]
3	Gómez-Cebrián N, Domingo-Ortí I, Poveda JL, Vicent MJ, Puchades-Carrasco L, Pineda-Lucena A. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments. Cancers (Basel) 2021;13:4544. [PMID: 34572770 DOI: 10.3390/cancers13184544] [Reference Citation Analysis]
4	Rodrigues-Ferreira S, Nahmias C. Predictive biomarkers for personalized medicine in breast cancer. Cancer Lett 2022;545:215828. [PMID: 35853538 DOI: 10.1016/j.canlet.2022.215828] [Reference Citation Analysis]
5	Zhang CD, Takeshima H, Sekine S, Yamashita S, Liu YY, Hattori N, Abe H, Yamashita H, Fukuda M, Imamura Y, Ushiku T, Katai H, Makino H, Watanabe M, Seto Y, Ushijima T. Prediction of tissue origin of adenocarcinomas in the esophagogastric junction by DNA methylation. Gastric Cancer 2021. [PMID: 34557982 DOI: 10.1007/s10120-021-01252-y] [Reference Citation Analysis]
6	Ueda K, Daito K, Ushijima H, Yane Y, Yoshioka Y, Tokoro T, Iwamoto M, Wada T, Makutani Y, Kawamura J. Laparoscopic complete mesocolic excision with central vascular ligation for splenic flexure colon cancer: short- and long-term outcomes. Surg Endosc 2021. [PMID: 34031741 DOI: 10.1007/s00464-021-08559-y] [Reference Citation Analysis]